Advertisement|Remove ads.

Penumbra Inc. (PEN) shares soared 14% in Thursday’s pre-market trade after Boston Scientific Corp. (BSX) announced an agreement to acquire the global healthcare company.
Boston Scientific stated that it has agreed to acquire Penumbra in a cash-and-stock transaction that values the latter at an enterprise value of $14.5 billion.
Boston Scientific shares were down nearly 3% in Thursday’s pre-market session. Retail sentiment on Stocktwits around Boston Scientific trended in the ‘bullish’ territory, while users felt ‘extremely bullish’ about Penumbra.
Get updates to this developing story directly on Stocktwits.
Also See: Spotify Hikes Premium Plan Price Across US, Select Markets — SPOT Stock Rises Pre-Market
For updates and corrections, email newsroom[at]stocktwits[dot]com.